Directory
>
Michael Keeley
Michael Keeley
Biopharmaceutical Program Leader | Crinetics Pharmaceuticals
San Francisco, California, United States
Michael Keeley
Summary
Michael Keeley is a seasoned Biopharmaceutical Program Leader based in San Francisco, California, with a robust background in biochemistry and biotechnology. He possesses extensive leadership experience across multiple therapy areas, including neuroscience and oncology, and has successfully managed cross-functional teams from IND preparation to late-stage development. His career includes significant roles at renowned firms such as Genentech and Novo Nordisk, where he honed his skills in product strategy and commercialization. Michael's academic credentials include a PhD in Molecular Biology and training at the University of Pennsylvania School of Medicine. He is recognized for his structured problem-solving approach, a skill he refined during his time at McKinsey. His passion for people development is evident as he has effectively mentored numerous direct reports. In addition to his technical expertise, Michael is also involved in investment through his role at Healthtech Capital, showcasing his interest in emerging technologies in the healthcare sector.
Michael Keeley
Work Experience
at
Present
Senior Project Manager, Liraglutide And Victoza at
Novo Nordisk
January 1970 - January 1970
Vice President, Product Team Leader at
Prothena
Program Lead In Early And Late-Stage Development, X-Fxn Product Strategy Leadership at
Genentech
Member, Investor at
Healthtech Capital Management LLC
Vice President, Global Product Team Leader at
Crinetics Pharmaceuticals
Associate at
McKinsey GmbH & Co. KG
Michael Keeley
Education
University of London, Master Of Science
January 1970 - January 1970
Bucknell University, Bachelors
January 1970 - January 1970
University of Pennsylvania School of Medicine, Doctorates
January 1970 - January 1970
KookMin University, Bachelors
Singularity University
Frequently Asked Questions about Michael Keeley
What is Michael Keeley email address?
Michael Keeley's primary email address is *******@healthtechcapital.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Keeley work for?
Michael Keeley is a Biopharmaceutical Program Leader at Crinetics Pharmaceuticals.
Where Michael Keeley graduated from?
Michael Keeley holds a degree in Masters from University of London.
How can I directly contact Michael Keeley?
To contact Michael Keeley directly, you can use the email address *******@healthtechcapital.com. Complete contact information is available upon registration with Muraena.
Who is Michael Keeley?
Michael Keeley is a seasoned Biopharmaceutical Program Leader based in San Francisco, California, with a robust background in biochemistry and biotechnology. He possesses extensive leadership experience across multiple therapy areas, including neuroscience and oncology, and has successfully managed cross-functional teams from IND preparation to late-stage development. His career includes significant roles at renowned firms such as Genentech and Novo Nordisk, where he honed his skills in product strategy and commercialization. Michael's academic credentials include a PhD in Molecular Biology and training at the University of Pennsylvania School of Medicine. He is recognized for his structured problem-solving approach, a skill he refined during his time at McKinsey. His passion for people development is evident as he has effectively mentored numerous direct reports. In addition to his technical expertise, Michael is also involved in investment through his role at Healthtech Capital, showcasing his interest in emerging technologies in the healthcare sector.
Michael`s contact details
*******@healthtechcapital.com
*******@crinetics.com
******@mail.med.upenn.edu
**************@mckinsey.com
*******@novonordisk.com
**************@prothena.com
**************@gene.com
Colleagues
Vice President, Project, Portfolio and Alliance Management
Chief of Staff and Head of Portfolio Strategy
Vice President of Market Access
Executive Director, Head of Corporate Strategy
Scientific Advisory Board Member
Member Board of Directors
Vice President, Health Economics and Outcomes Research
Vice President, Regulatory Affairs and Quality Assurance
Vice President, Marketing - Rare Diseases
Vice President, Global Product Lead